Hua Chen, MD, PhD

Use of metformin with second-generation antipsychotics (SGAs) was associated with improved adherence and persistence to SGAs at both 180- and 365-day follow-up in adults with Medicaid and commercial insurance.

Pediatric patients are vulnerable to antipsychotic-induced weight gain (AIWG). This study assessed the effectiveness of metformin on AIWG and explored whether timing of metformin initiation and premorbid obesity moderated...